These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24842566)

  • 1. Migraine and the Mu-opioidergic system-Can we directly modulate it? Evidence from neuroimaging studies.
    DaSilva AF; Nascimento TD; DosSantos MF; Zubieta JK
    Curr Pain Headache Rep; 2014 Jul; 18(7):429. PubMed ID: 24842566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-opioid receptors as targets for migraine therapy.
    Charles A; Pradhan AA
    Curr Opin Neurol; 2016 Jun; 29(3):314-9. PubMed ID: 27023737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
    Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK
    Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
    Kelley NE; Tepper DE
    Headache; 2012 Mar; 52(3):467-82. PubMed ID: 22404708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New migraine and pain research.
    Hargreaves R
    Headache; 2007 Apr; 47 Suppl 1():S26-43. PubMed ID: 17425708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.
    Smith YR; Stohler CS; Nichols TE; Bueller JA; Koeppe RA; Zubieta JK
    J Neurosci; 2006 May; 26(21):5777-85. PubMed ID: 16723535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in endogenous opioid functional measures in chronic back pain.
    Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK
    J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
    Nation KM; Dodick DW; Navratilova E; Porreca F
    Cephalalgia; 2019 Apr; 39(5):617-625. PubMed ID: 30286616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache.
    De Felice M; Ossipov MH; Porreca F
    Curr Opin Neurol; 2011 Jun; 24(3):193-6. PubMed ID: 21467931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors.
    Bie B; Pan ZZ
    J Neurosci; 2003 Aug; 23(19):7262-8. PubMed ID: 12917359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache.
    DaSilva AF; Nascimento TD; Love T; DosSantos MF; Martikainen IK; Cummiford CM; DeBoer M; Lucas SR; Bender MA; Koeppe RA; Hall T; Petty S; Maslowski E; Smith YR; Zubieta JK
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.
    Burford NT; Traynor JR; Alt A
    Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.
    Ansari H; Kouti L
    Curr Pain Headache Rep; 2016 Aug; 20(8):50. PubMed ID: 27457368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.
    Stone MT; Weed V; Kulich RJ
    Curr Pain Headache Rep; 2016 Sep; 20(9):51. PubMed ID: 27474093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.